Cargando…
Olanzapine Versus Haloperidol: Which Can Control Stuttering Better?
BACKGROUND: The aim of this study was to compare the effects of olanzapine versus haloperidol to control the signs and symptoms of stuttering. METHODS: Ninety-three patients were recruited in a 12-week single-blind randomized clinical trial, which was held between October 2009 and October 2010. Fort...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678230/ https://www.ncbi.nlm.nih.gov/pubmed/23776736 |
_version_ | 1782272832184516608 |
---|---|
author | Shaygannejad, Vahid Khatoonabadi, Seyed Ahmadreza Shafiei, Bijan Ghasemi, Majid Fatehi, Farzad Meamar, Rokhsareh Dehghani, Leila |
author_facet | Shaygannejad, Vahid Khatoonabadi, Seyed Ahmadreza Shafiei, Bijan Ghasemi, Majid Fatehi, Farzad Meamar, Rokhsareh Dehghani, Leila |
author_sort | Shaygannejad, Vahid |
collection | PubMed |
description | BACKGROUND: The aim of this study was to compare the effects of olanzapine versus haloperidol to control the signs and symptoms of stuttering. METHODS: Ninety-three patients were recruited in a 12-week single-blind randomized clinical trial, which was held between October 2009 and October 2010. Forty-three patients received olanzapine (5 mg/day) and 50 patients, haloperidol (2.5 mg/day). Before and after the study, they were evaluated by a speech pathologist by Van Riper's questionnaire. The data were analyzed using the SPSS version 16. T-test was used to compare the data between the two groups. RESULTS: Mean of stuttering score (SD) before treatment was 4.67 (0.81) and 4.40 (1.14) in haloperidol and olanzapine groups, respectively (P > 0.05). After treatment, the mean (SD) score was 2.87 (1.32) and 1.56 (0.71) in haloperidol and olanzapine groups, respectively (P = 0.000). CONCLUSIONS: It seems that olanzapine does have better impact in controlling stuttering, and it may be recommended to prescribe olanzapine for stutters as the first choice to control the stuttering under a careful follow-up. |
format | Online Article Text |
id | pubmed-3678230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36782302013-06-17 Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? Shaygannejad, Vahid Khatoonabadi, Seyed Ahmadreza Shafiei, Bijan Ghasemi, Majid Fatehi, Farzad Meamar, Rokhsareh Dehghani, Leila Int J Prev Med Original Article BACKGROUND: The aim of this study was to compare the effects of olanzapine versus haloperidol to control the signs and symptoms of stuttering. METHODS: Ninety-three patients were recruited in a 12-week single-blind randomized clinical trial, which was held between October 2009 and October 2010. Forty-three patients received olanzapine (5 mg/day) and 50 patients, haloperidol (2.5 mg/day). Before and after the study, they were evaluated by a speech pathologist by Van Riper's questionnaire. The data were analyzed using the SPSS version 16. T-test was used to compare the data between the two groups. RESULTS: Mean of stuttering score (SD) before treatment was 4.67 (0.81) and 4.40 (1.14) in haloperidol and olanzapine groups, respectively (P > 0.05). After treatment, the mean (SD) score was 2.87 (1.32) and 1.56 (0.71) in haloperidol and olanzapine groups, respectively (P = 0.000). CONCLUSIONS: It seems that olanzapine does have better impact in controlling stuttering, and it may be recommended to prescribe olanzapine for stutters as the first choice to control the stuttering under a careful follow-up. Medknow Publications & Media Pvt Ltd 2013-05 /pmc/articles/PMC3678230/ /pubmed/23776736 Text en Copyright: © International Journal of Preventive Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Shaygannejad, Vahid Khatoonabadi, Seyed Ahmadreza Shafiei, Bijan Ghasemi, Majid Fatehi, Farzad Meamar, Rokhsareh Dehghani, Leila Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? |
title | Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? |
title_full | Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? |
title_fullStr | Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? |
title_full_unstemmed | Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? |
title_short | Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? |
title_sort | olanzapine versus haloperidol: which can control stuttering better? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678230/ https://www.ncbi.nlm.nih.gov/pubmed/23776736 |
work_keys_str_mv | AT shaygannejadvahid olanzapineversushaloperidolwhichcancontrolstutteringbetter AT khatoonabadiseyedahmadreza olanzapineversushaloperidolwhichcancontrolstutteringbetter AT shafieibijan olanzapineversushaloperidolwhichcancontrolstutteringbetter AT ghasemimajid olanzapineversushaloperidolwhichcancontrolstutteringbetter AT fatehifarzad olanzapineversushaloperidolwhichcancontrolstutteringbetter AT meamarrokhsareh olanzapineversushaloperidolwhichcancontrolstutteringbetter AT dehghanileila olanzapineversushaloperidolwhichcancontrolstutteringbetter |